Current regulatory (draft) guidance on chiral medicinal products: Canada, EEC, Japan, United States

The rapid development of stereospecific analytical, synthetic, and preparative methods has profoundly changed the prospects for development and application of chiral medicinal products. This has induced regulatory agencies, e.g., in Canada, the EEC, Japan, and the United States, to prepare guidance...

Full description

Saved in:
Bibliographic Details
Published inChirality (New York, N.Y.) Vol. 6; no. 2; p. 72
Main Authors Rauws, A G, Groen, K
Format Journal Article
LanguageEnglish
Published United States 1994
Subjects
Online AccessGet more information

Cover

Loading…